Comprehensive Genomic Profiling in Community Oncology
Recommendations to address limitations in more widespread use of reflex testing in community oncology.
Future Outlook: Comprehensive Genomic Profiling in Oncology
Expectations regarding the future utilization of comprehensive genomic profiling in clinical practice to assess patients with solid tumor cancers.
Molecular Testing Turnaround Times and Treatment Decisions
Variables that impact decisions to initiate therapy for solid tumor cancers versus wait for results of genomic profiling assays.
Comprehensive Genomic Profiling: When to Retest Patients
Oncologists explain scenarios for which they may retest patients previously assessed via genomic profiling.
Molecular Testing in Oncology: Current Practice Patterns
Oncologists describe how they use molecular profiling in their practices to assess patients with solid tumor cancers.
Comprehensive Genomic Profiling and Clinical Actionability
Payer response to supporting decisions for coverage of comprehensive genomic profiling in oncology.
Shifting Over to Comprehensive Genomic Profiling in Oncology
The rationale for migrating away from single, spot testing to comprehensive genomic profiling assays in oncology.
Types of Molecular Assays Used in Oncology
Oncologists who manage patients with solid tumors compare and contrast current comprehensive molecular assays being used in clinical practice and discuss reimbursement criteria with payer, Eugean Jiwanmall, MPH, MBA.
Information Provided by Comprehensive Genomic Profiling Assays
Information that can be extracted from results of comprehensive genomic profiling assays and used to guide treatment decisions in oncology.
2 Clarke Drive Cranbury, NJ 08512